Literature DB >> 8832338

Adrenaline, cardiac arrest, and evidence based medicine.

T H Rainer1, C E Robertson.   

Abstract

In this article we review the evidence supporting the clinical application of adrenaline in cardiopulmonary arrest, and summarize the receptor effects of catecholamines and the basic principles producing perfusion during CPR. Animal and human studies show that in cardiac arrest, adrenaline has positive haemodynamic effects, increasing systemic pressures, myocardial perfusion, and cerebrally directed flow. The problems extrapolating from animal to human data are highlighted. Studies showing improvements in short term survival outcomes with high dose regimens have not been confirmed by other large prospective randomised trials. There is no evidence that high doses of adrenaline improve survival to hospital discharge. Most studies comparing adrenaline with placebo have been non-randomised and uncontrolled, with major methodological problems. Conclusions are difficult, but if anything adrenaline is associated with poorer outcomes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8832338      PMCID: PMC1342718          DOI: 10.1136/emj.13.4.234

Source DB:  PubMed          Journal:  J Accid Emerg Med        ISSN: 1351-0622


  35 in total

1.  Optimizing myocardial supply/demand balance with alpha-adrenergic drugs during cardiopulmonary resuscitation.

Authors:  J J Livesay; D M Follette; K H Fey; R L Nelson; E C DeLand; R J Barnard; G D Buckberg
Journal:  J Thorac Cardiovasc Surg       Date:  1978-08       Impact factor: 5.209

2.  Role of carotid artery resistance to collapse during high-intrathoracic-pressure CPR.

Authors:  F C Yin; J M Cohen; J Tsitlik; B Zola; M L Weisfeldt
Journal:  Am J Physiol       Date:  1982-08

3.  The comparative effects of epinephrine versus phenylephrine on regional cerebral blood flow during cardiopulmonary resuscitation.

Authors:  C G Brown; F Birinyi; H A Werman; E A Davis; R L Hamlin
Journal:  Resuscitation       Date:  1986-11       Impact factor: 5.262

4.  Beta-adrenergic modulation of direct defibrillation energy in anesthetized dog heart.

Authors:  R Ruffy; K Schechtman; E Monje
Journal:  Am J Physiol       Date:  1985-05

5.  High dose and standard dose adrenaline do not alter survival, compared with placebo, in cardiac arrest.

Authors:  S P Woodhouse; S Cox; P Boyd; C Case; M Weber
Journal:  Resuscitation       Date:  1995-12       Impact factor: 5.262

6.  Adrenergically mediated variations in the energy required to defibrillate the heart: observations in closed-chest, nonanesthetized dogs.

Authors:  R Ruffy; K Schechtman; E Monje; J Sandza
Journal:  Circulation       Date:  1986-02       Impact factor: 29.690

7.  Effect of epinephrine on defibrillation in ischemic ventricular fibrillation.

Authors:  C W Otto; R W Yakaitis; G A Ewy
Journal:  Am J Emerg Med       Date:  1985-07       Impact factor: 2.469

8.  Spontaneous ischemic ventricular fibrillation in dogs: a new model for the study of cardiopulmonary resuscitation.

Authors:  C W Otto; R W Yakaitis; G A Ewy
Journal:  Crit Care Med       Date:  1983-11       Impact factor: 7.598

9.  Influence of time and therapy on ventricular defibrillation in dogs.

Authors:  R W Yakaitis; G A Ewy; C W Otto; D L Taren; T E Moon
Journal:  Crit Care Med       Date:  1980-03       Impact factor: 7.598

10.  Adrenomedullary response to maximal stress in humans.

Authors:  J Wortsman; S Frank; P E Cryer
Journal:  Am J Med       Date:  1984-11       Impact factor: 4.965

View more
  2 in total

1.  Adrenaline, cardiac arrest and evidence based medicine.

Authors:  V Inyang
Journal:  J Accid Emerg Med       Date:  1996-11

2.  Paramedics, technicians, and survival from out of hospital cardiac arrest.

Authors:  T H Rainer; R Marshall; S Cusack
Journal:  J Accid Emerg Med       Date:  1997-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.